FYI - For Your Innovation

On this FYI episode, we are joined by Sean George, CEO and co-founder of Invitae one of the innovative frontrunners in the medical genetic testing space. (This episode was recorded: Sep. 10, 2019) Invitae is driven by the provision of affordable genetic testing, clinical-grade accuracy, and transparent reporting practices. In asking different questions than anyone else in the space, Invitae is spearheading a paradigm shift in the diagnostics industry.1

For them, finding scalable solutions, where anyone can access information about medical risks they face and then tailor solutions accordingly, is an ideal outcome. Sean also talks about the declining costs of DNA sequencing and the implications it has for the future of the medical genetics testing industry along with the host of other industries it will benefit. He also touches on how genetic testing can continue to change cancer treatment to ensure that all patients get comprehensive, tailored treatments that deal with the specificities of their case. While being an innovator in this space has provided altruistic benefits for many people outside of the company, finding investors has at times proved to be challenging for Invitae. Sean then gets into what the current investment landscape for biotech companies looks like as well as his suggestions for raising capital moving forward. For all this and more, join us today!

Today’s episode is part two of the discussion with Professor Yaakov Nahmias, the Israeli biomedical engineer and innovator. We discuss his startup, Future Meat Technologies, a company funded by Tyson Foods, which is poised to develop the next generation of cultured meat.

Initially when someone proposed the idea of cultured meat to him, Yaakov thought it would be too expensive. Drawing inspiration from the human body’s filtration and purification system, Future Meat Technologies is working on a bioreactor which removes the growth inhibiting ammonia from the cell growth process. With this breakthrough development, the company has a plan to drastically drive down the cost of cultured meat production and improve efficiency to the point where it could surpass the output of the conventional meat industry. This may not only feed more people, but also allow consumers to make more conscious decisions. Yaakov recognizes that it is a niche market and in order to widen the customer base it is important to make the product as close to conventional meat as possible.

Today on the podcast we are joined by Ric Edelman, the founder and chairman of Edelman Financial Engines and author of The Truth About Your Future. We also have our very own Cathie Wood join us for the conversation as we look at the current state of bitcoin and cryptocurrencies, a decade after they emerged into the public imagination. We hear from Ric about his early theoretical and then practical interactions with bitcoin, his ongoing belief in the platform, its limitations and what its future may look like. Cathie also weighs in on ARK’s initial relationship with bitcoin and how cryptocurrencies informed the formation of the company. We discuss bitcoin’s strengths and weaknesses, who can most benefit from its unique characteristics at present and the advantages that would emerge with the involvement of the SEC. Tune in to hear this engaging discussion on what we believe to be one of the decade’s defining technologies!

On the podcast today, we are joined by Steve Forbes, Chairman and Editor in Chief of Forbes Media Group. Together with ARK CEO and CIO Cathie Wood and ARK analyst James Wang, we have a fascinating chat with Steve on the market, the modern media landscape, and the trustworthiness of cryptocurrencies. The podcast starts off […]

On the podcast today, we are joined by Steve Forbes, Chairman and Editor in Chief of Forbes Media Group. Together with ARK CEO and CIO Cathie Wood and ARK analyst James Wang, we have a fascinating chat with Steve on the market, the modern media landscape, and the trustworthiness of cryptocurrencies.

The podcast starts off looking at the current economic climate, doom and gloom predictions, and why Steve has come out publicly with a relatively optimistic outlook. From there we naturally move into taxation, the market, and all the political issues connected to these topics. Steve gives us his views on the path of Forbes Media Group through the internet age. We hear about the philosophy that guided the company from its previous iteration as a purely print publication, into the online powerhouse we see today. We even broaden our conversation into a comparison of today’s popular music landscape. Lastly, we focus on cryptocurrencies, the concept of trustworthiness of Bitcoin, and some of Steve’s current and upcoming projects. Be sure not to miss this great episode!

In this episode of the FYI—For Your Innovation podcast, we welcome Professor Yaakov Nahmias from the Hebrew University. Yaakov is an Israeli bioengineer and an award-winning, industry-leading expert in his fields, who has worked in 3D printing and cellular research for the majority of his career. This two-part conversation will cover his work at Tissue Dynamics in the field of drug discovery and the production of cost-effective cultured meat at Future Meat Technologies.

In this first part, we explore how Professor Nahmias is helping to advance medical research, drug discovery, and production of new medicines. We hear about his ideas that led to the founding of his company, Tissue Dynamics, and some of the problems that the company aims to fix. Professor Nahmias does a great job of explaining the complex issues of drug discovery. We discuss technological advancements, such as smart organ-on-chip technology, that could allow us to reduce the time it takes to find new drugs. For this and more, tune in!

For today’s show we welcome Brett Winton, ARK’s Director of Research, to discuss his recent white paper titled Disruptive Innovation – Why Now? The main idea of the paper explores innovation today and how the convergence of five major innovation platforms compares to other innovation periods in our history. Brett details the five technologies that we have identified as transformative signposts today. To unpack just how exciting and unprecedented this is, we look at comparable innovation platforms, their criteria, and impact on our economy. We explore the importance of technologies evolving simultaneously and the exponential nature of stacked innovation platforms. Lastly, we discuss how innovation could impact investing and the different growth industries.

Andrew Feldman, co-founder and CEO of Cerebras, joins us this week to discuss the Wafer Scale Engine, or WSE, an AI chip that is 50 times larger than the largest chips produced by Nvidia and Intel. This radical design has raised a lot of eyebrows and it is already being heralded as the biggest breakthrough […]

Andrew Feldman, co-founder and CEO of Cerebras, joins us this week to discuss the Wafer Scale Engine, or WSE, an AI chip that is 50 times larger than the largest chips produced by Nvidia and Intel. This radical design has raised a lot of eyebrows and it is already being heralded as the biggest breakthrough in semi-conductor technology in decades. Andrew helps us unpack why AI work needs chips this large, how Cerebras was able to leapfrog industry incumbents, and what why the Wafer Scale Engine is the ideal AI training accelerator. Join us on this podcast as we talk with Andrew about some of the biggest hurdles that his team encountered on this market shifting journey.

The Vibrant Online Education Space with Aaron Nace